Publication:
ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer

Simple item page
dc.conference.dateNOV 20-22, 2020
dc.conference.locationELECTR NETWORK
dc.contributor.coauthorLorusso, D.
dc.contributor.coauthorXiang, Y.
dc.contributor.coauthorColombo, N.
dc.contributor.coauthorColeman, R.
dc.contributor.coauthorRandall, L.
dc.contributor.coauthorDuska, L.
dc.contributor.coauthorHasegawa, K.
dc.contributor.coauthorNogueira-Rodrigues, A.
dc.contributor.coauthorCibula, D.
dc.contributor.coauthorMirza, M. R.
dc.contributor.coauthorYou, B.
dc.contributor.coauthorOaknin, A.
dc.contributor.coauthorChristiaens, M.
dc.contributor.coauthorSehouli, J.
dc.contributor.coauthorKorach, J.
dc.contributor.coauthorMarth, C.
dc.contributor.coauthorKeefe, S.
dc.contributor.coauthorPuglisi, M.
dc.contributor.coauthorPignata, S.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorTaşkıran, Çağatay
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2026-01-09T06:07:13Z
dc.date.available2026-01-09
dc.date.issued2020
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipMerck Sharp Dohme Corp.
dc.identifier.doi10.1016/j.annonc.2020.10.248
dc.identifier.eissn1569-8041
dc.identifier.embargoNo
dc.identifier.endpageS1342
dc.identifier.issn0923-7534
dc.identifier.quartileQ1
dc.identifier.scopusN/A
dc.identifier.startpageS1341
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2020.10.248
dc.identifier.urihttps://hdl.handle.net/20.500.14288/31924
dc.identifier.volume31
dc.identifier.wos000600988900257
dc.language.isoeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofAnnals of Oncology
dc.relation.ispartofESMO Asia Virtual Congress
dc.relation.openaccessNo
dc.rightsCopyrighted
dc.subjectOncology
dc.titleENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer
dc.typeMeeting Abstract
dspace.entity.typePublication
person.familyNameTaşkıran
person.givenNameÇağatay
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext